Morgan Stanley predicts CMR to be dropped from S&P Index, September. http://www.fnarena.com/index2.cfm?type=dsp_newsitem&n=AA6AD704-17A4-1130-F50AA35D8245210EDYOR.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status